ALB and hepatocellular carcinoma: Patients with LC had higher AST, ALT, and total bilirubin levels; a higher INR; a higher proportion of HCV infection, DM, Child–Pugh class B, and HCC with macrovascular invasion (MVI); a lower platelet count; lower albumin and creatinine levels; a lower proportion of men and HBV infection; and a shorter follow-up duration and median OS (35.48 months vs. not reached, p < 0.001) than those without LC.